Replies to post #672902 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

This DcVax-L trial has its own psPD arm with 32 patients that they stopped enrolling into as of May 2014 (but you know that already). So those who were Chemo/rad psPD patients for the most part enrolled that arm (which is likely now part of the Expanded Access Protocol (EAP) trial.)

Numbers do vary, and a good number of chemo/rad psPD patients present during those first three months. That’s why the trial was set up that way.